Frontage Holdings's book value per share for the quarter that ended in Dec. 2023 was HK$1.31.
During the past 12 months, Frontage Holdings's average Book Value Per Share Growth Rate was 3.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 6.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 36.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Frontage Holdings was 141.60% per year. The lowest was 6.10% per year. And the median was 92.70% per year.
Frontage Holdings's current price is HK$1.26. Its book value per share for the quarter that ended in Dec. 2023 was HK$1.31. Hence, today's PB Ratio of Frontage Holdings is 0.96.
During the past 8 years, the highest P/B Ratio of Frontage Holdings was 31.53. The lowest was 0.94. And the median was 3.44.
Good Sign:
Frontage Holdings Corp stock PB Ratio (=0.98) is close to 5-year low of 0.94
Frontage Holdings Book Value per Share Historical Data
The historical data trend for Frontage Holdings's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Frontage Holdings's Book Value per Share
For the Biotechnology subindustry, Frontage Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frontage Holdings's PB Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Frontage Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Frontage Holdings's PB Ratio falls into.
Frontage Holdings Book Value per Share Calculation
Frontage Holdings's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
Frontage Holdings (HKSE:01521) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Frontage Holdings Book Value per Share Related Terms
Thank you for viewing the detailed overview of Frontage Holdings's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Frontage Holdings (HKSE:01521) Business Description
Frontage Holdings Corp is a contract research organization providing integrated, scientifically driven research, analytical and development services. Geographically the group operates in both PRC and North America. The services provided in the North American segment, include Bioanalytical, CMC, DMPK and Safety and Toxicology services in the USA and Canada. The service offered in PRC includes Bioanalytical, Bioequivalence and CMC services in the PRC. Further, it also provides bioanalytical services, which are offered throughout the drug discovery and development process both in the United States and China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01521 has been successfully added to your 